Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Zhou, Zhenhai ^a,b   Niu, Haitao ^a,c   Zheng, Ying Yi ^a   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; DNA ANTIBODY; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL SECRETION; CELLULAR DISTRIBUTION; EFFECTOR CELL; FEMALE; GENE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MARGINAL ZONE B CELL; MOUSE; NONHUMAN; SLE GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL COMMUNICATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DISEASE PREDISPOSITION; GENE LOCUS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SPLEEN;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, SURFACE; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL MOVEMENT; CELL PROLIFERATION; DISEASE SUSCEPTIBILITY; GENETIC LOCI; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; SPLEEN;

EID: 78651579774     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-7     Document Type: Article

References (42)

1. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001, 2:764-766. 10.1038/ni0901-764, 11526379.
2. Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001, 1:177-186. 10.1038/35105052, 11905826.
3. Cinamon G, Zachariah MA, Lam OM, Foss FW, Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008, 9:54-62. 10.1038/ni1542, 2488964, 18037889.
4. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004, 172:803-811.
5. Snapper CM, Yamada H, Smoot D, Sneed R, Lees A, Mond JJ. Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol 1993, 150:2737-2745.
6. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997, 27:2366-2374. 10.1002/eji.1830270935, 9341782.
7. Oliver AM, Martin F, Kearney JF. IgMhigh CD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999, 162:7198-7207.
8. Gunn KE, Brewer JW. Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J Immunol 2006, 177:3791-3798.
9. Mandik-Nayak L, Racz J, Sleckman BP, Allen PM. Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med 2006, 203:1985-1998. 10.1084/jem.20060701, 2118363, 16880262.
10. Phan TG, Gardam S, Basten A, Brink R. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J Immunol 2005, 174:4567-4578.
11. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1B cells as part of a "natural immune memory". Immunol Rev 2000, 175:70-79. 10.1111/j.1600-065X.2000.imr017515.x, 10933592.
12. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 1995, 182:559-566. 10.1084/jem.182.2.559, 2192131, 7629512.
13. Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 1998, 188:1691. 10.1084/jem.188.9.1691, 2212517, 9802981.
14. Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 2006, 203:393-400. 10.1084/jem.20052033, 2118214, 16446381.
15. Grimaldi CM, Michael DJ, Diamond B. Cutting Edge: Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001, 167:1886-1890.
16. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710. 10.1084/jem.190.11.1697, 2195729, 10587360.
17. Wither JE, Loh C, Lajoie G, Heinrichs S, Cai YC, Bonventi G, MacLeod R. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J Immunol 2005, 175:4309-4319.
18. Amano H, Amano E, Moll T, Marinkovic D, Ibnou-Zekri N, Martinez-Soria E, Semac I, Wirth T, Nitschke L, Izui S. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol 2003, 170:2293-2301.
19. Atencio S, Amano H, Izui S, Kotzin BL. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol 2004, 172:4159-4166.
20. Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, Wakeland EK. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 2000, 97:6670-6675. 10.1073/pnas.97.12.6670, 18697, 10841565.
21. Duan B, Niu H, Xu Z, Sharpe AH, Croker BP, Sobel ES, Morel L. Intrafollicular location of marginal zone/CD1dhi B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest 2008, 88:1008-1019. 10.1038/labinvest.2008.62, 18607347.
22. Duan B, Croker BP, Morel L. Lupus resistance is associated with marginal zone abnormalities in an NZM murine model. Lab Invest 2007, 87:14-28. 10.1038/labinvest.3700497, 17170739.
23. Li H, Jiang Y, Prak EL, Radic M, Weigert M. Editors and editing of anti-DNA receptors. Immunity 2001, 15:947-957. 10.1016/S1074-7613(01)00251-5, 11754816.
24. Shlomchik MJ, Zharhary D, Saunders T, Camper SA, Weigert MG. A rheumatoid-factor transgenic mouse model of autoantibody regulation. Int Immunol 1993, 5:1329-1341. 10.1093/intimm/5.10.1329, 8268138.
25. Fields ML, Erikson J. The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models. Curr Opin Immunol 2003, 15:709-717. 10.1016/j.coi.2003.09.016, 14630207.
26. Liu Y, Li L, Kumar KR, Xie C, Lightfoot S, Zhou XJ, Kearney JF, Weigert M, Mohan C. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol 2007, 179:1340-1352.
27. Pereira JP, Kelly LM, Cyster JG. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. Int Immunol 2010, 22:413-419. 10.1093/intimm/dxq047, 20508253.
28. Chen Y, Cuda C, Morel L. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J Immunol 2005, 174:7692-7702.
29. Wither JE, Roy V, Brennan LA. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB × NZW)F-1 mice. Clin Immunol 2000, 94:51-63. 10.1006/clim.1999.4806, 10607490.
30. Rolf J, Motta V, Duarte N, Lundholm M, Berntman E, Bergman ML, Sorokin L, Cardell SL, Holmberg D. The enlarged population of marginal zone/CD1dhigh B lymphocytes in Nonobese Diabetic Mice maps to diabetes susceptibility region Idd11. J Immunol 2005, 174:4821-4827.
31. Marino E, Batten M, Groom J, Walters S, Liuwantara D, Mackay F, Grey ST. Marginal zone B cells of Non-obese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes and present auto-antigen to diabetogenic T cells. Diabetes 2007, 57:395-404. 10.2337/db07-0589, 18025414.
32. Erickson LD, Lin LL, Duan B, Morel L, Noelle RJ. A genetic lesion that arrests plasma cell homing to the bone marrow. Proc Natl Acad Sci USA 2003, 100:12905-12910. 10.1073/pnas.2131686100, 240717, 14555759.
33. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607. 10.1038/416603a, 11948342.
34. Wu T, Qin X, Kurepa Z, Kumar KR, Liu K, Kanta H, Zhou XJ, Satterthwaite AB, Davis LS, Mohan C. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 2007, 117:2186-2196. 10.1172/JCI30398, 1913486, 17641780.
35. Rubtsov AV, Swanson CL, Troy S, Strauch P, Pelanda R, Torres RM. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J Immunol 2008, 180:3882-3888.
36. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 2007, 178:7779-7786.
37. Rahman ZSM, Manser T. Failed up-regulation of the inhibitory IgG Fc receptor FcgRIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the FcgRIIB gene. J Immunol 2005, 175:1440-1449.
38. Burlingame RW, Rubin RL. Autoantibody to the nucleosome subunit (H2A-H2B)-DNA is an early and ubiquitous feature of lupus-like conditions. Mol Biol Rep 1996, 23:159-166. 10.1007/BF00351164, 9112224.
39. Herlands RA, William J, Hershberg U, Shlomchik MJ. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol 2007, 37:3339-3351. 10.1002/eji.200737752, 18034429.
40. Boackle SA, Holers VM, Chen XJ, Szakonyi G, Karp DR, Wakeland EK, Morel L. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001, 15:775-785. 10.1016/S1074-7613(01)00228-X, 11728339.
41. Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004, 199:1631-1640. 10.1084/jem.20031942, 2212813, 15197227.
42. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome - A major immunogen for pathogenic autoantibody-inducing T-cells of lupus. J Exp Med 1993, 177:1367-1381. 10.1084/jem.177.5.1367, 2191002, 8478612.